col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world

Wiley: Transfusion
  original article Date Title Authors   All Authors
1 [GO] 2021―Jul―16 Treating the endotheliopathy of SARS-CoV -2 infection with plasma: Lessons learned from optimized trauma resuscitation with blood products Shibani Pati, Erin Fennern, John B. Holcomb, Mark Barry, Alpa Trivedi, Andrew P. Cap, et al. (+7)
2 [GO] 2021―Jun―21 Lewis and ABO histo-blood types and the secretor status of patients hospitalized with COVID -19 implicate a role for ABO antibodies in susceptibility to infection with SARS-CoV -2 Eva Maria Matzhold, Andrea Berghold, Maria Karin Berta Bemelmans, Chiara Banfi, Evelyn Stelzl, Harald Hans Kessler, et al. (+5)
3 [GO] 2021―Jun―14 SARS-CoV -2 Antibody persistence in COVID -19 convalescent plasma donors: Dependency on assay format and applicability to serosurveillance Clara Di Germanio, Graham Simmons, Kathleen Kelly, Rachel Martinelli, Orsolya Darst, Mahzad Azimpouran, et al. (+12)
4 [GO] 2021―May―28 Minipool testing for SARS-CoV -2 RNA in United States blood donors Sonia Bakkour, Paula Saá, Jamel A. Groves, Leilani Montalvo, Clara Di Germanio, Sonja M. Best, et al. (+12)
5 [GO] 2021―May―27 Are We Forgetting About IgA? A Re-examination of Coronavirus Disease 2019 Convalescent Plasma Hans Verkerke, Bejan J. Saeedi, Darra Boyer, Jerry W. Allen, Joshua Owens, Sooncheon Shin, et al. (+15)
6 [GO] 2021―May―26 The effect of the SARS-CoV -2 pandemic and civil unrest on massive transfusion protocol activations in Minneapolis 2020 Alexander L. Braun, Jed B. Gorlin, Jessica Peters, Sherrie Murphy, Nancy L. Van Buren
7 [GO] 2021―May―26 Blood group O convalescent plasma donations have significantly lower levels of SARS-CoV -2 IgG antibodies compared to blood group A donations Chelsea Hayes, Wesley Rubenstein, David Gibb, Ellen Klapper, Julie Tanaka, Samuel Pepkowitz
8 [GO] 2021―May―15 Impact of the early COVID -19 pandemic on blood utilization in the United States: a time-series analysis of data reported to the National Healthcare Safety Network Hemovigilance Module Ian Kracalik, Sanjida Mowla, Louis Katz, Melissa Cumming, Matthew R. P. Sapiano, Sridhar V. Basavaraju
9 [GO] 2021―May―09 We stand ready … Blood collection organizations and the COVID -19 pandemic Hany Kamel
10 [GO] 2021―Apr―27 Implementation of Measures to Improve Blood Collection Center Employee Safety and Reduce Callouts During The COVID -19 Pandemic Emily Coberly, Erin Korich, Michelle Henesy, Kate Doerksen, Pampee Young
11 [GO] 2021―Apr―21 Blood usage at a large academic center in Maryland in relation to the COVID -19 pandemic in 2020 Colin Murphy, Magali Fontaine, Paul Luethy, Heather McGann, Bryon Jackson
12 [GO] 2021―Mar―08 The Impact of ABO Blood Group on Clinical Outcomes and Susceptibility to COVID-19: A Retrospective Study in an Unselected Population Sarah A. Al-Youha, Waleed Alduaij, Ahmad Al-Serri, Sulaiman M. Almazeedi, Mohannad Al-Haddad, Mohammad H. Jamal, et al. (+2)
13 [GO] 2021―Mar―08 Planned haematopoietic stem cell transplantation in a 17-month-old patient with high-risk acute myeloid leukaemia and persistent SARS-CoV -2 infection Daniela Cuzzubbo, Francesco Pegoraro, Stefano Frenos, Tommaso Casini, Luisa Galli, Eleonora Gambineri, et al. (+3)
14 [GO] 2021―Mar―05 ABO blood type association with SARS-CoV -2 infection mortality: A single-center population in New York City James Szymanski, Laurel Mohrmann, Jamal Carter, Randin Nelson, Sweta Chekuri, Andrei Assa, et al. (+5)
15 [GO] 2021―Mar―01 National level adjustments to the challenges of the SARS-CoV2 pandemic on blood banking operations Andrea Matusovits, Sándor Nagy, Klára Baróti-Tóth, János Nacsa, Mária Lázár, Imelda Marton, et al. (+3)
16 [GO] 2021―Feb―26 New blood donors in times of crisis: Increased donation willingness, particularly among people at high risk for attracting SARS-CoV -2 Marloes L. C. Spekman, Steven Ramondt, Franke A. Quee, Femmeke J. Prinsze, Elisabeth M. J. Huis in 't Veld, Katja Hurk, Eva-Maria Merz
17 [GO] 2021―Feb―23 Apheresis Physician Well-Being During the COVID -19 Pandemic: Results of a Survey Yvette C. Tanhehco, Yanhua Li, Nicole D. Zantek, Joanne Becker, Mohamed Alsammak, Kael Mikesell, et al. (+5)
18 [GO] 2021―Feb―22 Longitudinal analysis of SARS-CoV -2 antibodies in 8000 U.S. first-time convalescent plasma donations Michael Karbiener, Maria R. Farcet, Reinhard Ilk, Jessica Schreiner, James Lenart, Nicholas Powers, et al. (+3)
19 [GO] 2021―Feb―20 A longitudinal study of convalescent plasma ( CCP ) donors and correlation of ABO group, initial neutralizing antibodies ( nAb ), and body mass index ( BMI ) with nAb and anti-nucleocapsid ( NP ) SARS-CoV -2 antibody kinetics: Proposals for better quality of CCP collections Silvano Wendel, Rita Fontão-Wendel, Roberta Fachini, Gabriela Candelaria, Patricia Scuracchio, Ruth Achkar, et al. (+8)
20 [GO] 2021―Feb―20 High-throughput detection of antibodies targeting the SARS-CoV -2 Spike in longitudinal convalescent plasma samples Sai Priya Anand, Jérémie Prévost, Jonathan Richard, Josée Perreault, Tony Tremblay, Mathieu Drouin, et al. (+4)
21 [GO] 2021―Feb―17 COVID -19 antibody screening with SARS-CoV -2 red cell kodecytes using routine serologic diagnostic platforms Radhika Nagappan, Willy A. Flegel, Kshitij Srivastava, Eleanor C. Williams, Ivan Ryzhov, Alexander Tuzikov, et al. (+6)
22 [GO] 2021―Feb―14 Decrease in serum antibodies to SARS-CoV -2 in convalescent plasma donors over time Kristina Prus, Caroline R. Alquist, Jose A. Cancelas, David Oh
23 [GO] 2021―Feb―14 Testing for the presence of SARS-CoV -2 RNA in presymptomatic blood donors Lionel Loubaki, Pierre Gantner, Amélie Pagliuzza, Hugues Fausther-Bovendo, Gary Kobinger, Nicolas Chomont, Marc Germain
24 [GO] 2021―Feb―08 Pandemic Blood Donor Demographics - Do Changes Impact Blood Safety? Ralph R. Vassallo, Marjorie D. Bravo, Hany Kamel
25 [GO] 2021―Feb―08 Selecting COVID -19 Convalescent Plasma for Neutralizing Antibody Potency Using a High-capacity SARS-CoV -2 Antibody Assay E. Goodhue Meyer, G. Simmons, E. Grebe, M. Gannett, S. Franz, O. Darst, et al. (+10)
26 [GO] 2021―Feb―03 SARS-CoV -2 seroprevalence among blood donors after the first COVID -19 wave in Canada Sahar Saeed, Steven J. Drews, Chantale Pambrun, Qi-Long Yi, Lori Osmond, Sheila F. O’Brien
27 [GO] 2021―Jan―25 Correlation between SARS-COV-2 antibody screening by immunoassay and neutralizing antibody testing Alfredo Mendrone-Junior, Carla Luana Dinardo, Suzete Cleuza Ferreira, Anna Nishya, Nanci Alves Salles, Cesar Almeida Neto, et al. (+8)
28 [GO] 2021―Jan―18 Covid-19 Convalescent Plasma Donor Characteristics, Product Disposition and Comparison With Standard Apheresis Donors Baia Lasky, Erin Goodhue Meyer, Whitney R Steele, Lauren A. Crowder, Pampee P. Young
29 [GO] 2021―Jan―16 Presence and short-term persistence of SARS-CoV -2 neutralizing antibodies in COVID -19 convalescent plasma donors Kyle Annen, Thomas E. Morrison, Melkon G. DomBourian, Mary K. McCarthy, Leah Huey, Patricia A. Merkel, et al. (+3)
30 [GO] 2021―Jan―16 Adaptations of transfusion systems to the COVID -19 pandemic in British Columbia, Canada : Early experiences of a large tertiary care center and survey of provincial activities Eric McGinnis, Robert J. Guo, Krista M. Marcon, Brian Berry, Robert Coupland, Victor Meneghetti, et al. (+6)
31 [GO] 2021―Jan―15 Neutralizing Activity to SARS-CoV-2 of Convalescent and Control Plasma Used in a Randomized Controlled Trial Alex T. Freedenberg, Chun-Hao Pan, William E. Diehl, Jamie L. Romeiser, Ga-Ram Hwang, Cindy V. Leiton, et al. (+3)
32 [GO] 2020―Dec―25 De novo acquired hemophilia as an immune dysregulation phenomenon following SARS-CoV -2 infection Gregory M. Olsen, Henry M. Rinder, Christopher A. Tormey
33 [GO] 2020―Dec―25 Simple Modifications of Therapeutic Plasma Exchange Treatments during the SARS-CoV -2 Pandemic Jack Khouri, Jennifer Royer, Heather Howdyshell, Shannon Homolish, Linda Salmi, Viva Veemara, et al. (+2)
34 [GO] 2020―Dec―04 COVID-19 associated with severe autoimmune hemolytic anemia Jeremy Jacobs, Quentin Eichbaum
35 [GO] 2020―Nov―24 Therapeutic Plasma Exchange for COVID-19-Associated Hyperviscosity Alexander D. Truong, Sara C. Auld, Nicholas A. Barker, Sarah Friend, A. Thanushi Wynn, Jason Cobb, et al. (+14)
36 [GO] 2020―Nov―21 Transfusion services operations during the COVID -19 pandemic: Results from AABB survey Monica B. Pagano, Srijana Rajbhandary, Eduardo Nunes, Claudia S. Cohn
37 [GO] 2020―Nov―20 Blood component utilization in COVID-19 patients in New York City : Transfusions do not follow the curve Robert A. DeSimone, Victoria A. Costa, Kathleen Kane, Jorge L. Sepulveda, Grant B. Ellsworth, Roy M. Gulick, et al. (+4)
38 [GO] 2020―Nov―16 Lack of association between SNPsrs8176719(O blood group) and COVID-19: data from Spanish age matched patients and controls Eliecer Coto, Guillermo M. Albaiceta, Marta G. Clemente, Juan Gómez
39 [GO] 2020―Nov―04 Transfusion support in COVID-19 patients: Impact on hospital blood component supply during the outbreak Kyra Velázquez-Kennedy, Alejandro Luna, Adrián Sánchez-Tornero, Carlos Jiménez-Chillón, Ana Jiménez-Martín, Ana Vallés Carboneras, et al. (+4)
40 [GO] 2020―Oct―30 Transfusion Reactions Associated with COVID -19 Convalescent Plasma Therapy for SARS-CoV -2 Freddy T. Nguyen, Tayler Akker, Kimberly Lally, Hansen Lam, Volha Lenskaya, Sean T. H. Liu, et al. (+40)
41 [GO] 2020―Oct―30 Validation of a SARS-CoV -2 RNA RT-PCR assay for high-throughput testing in blood of COVID -19 convalescent plasma donors and patients EF Strasser, PA Steininger, K Korn, S Achenbach, M Tenbusch, S Cunningham, et al. (+3)
42 [GO] 2020―Oct―26 Neutralizing and binding activities against SARS-CoV -1/2, MERS-CoV , and human coronaviruses 229E and OC43 by normal human intravenous immunoglobulin derived from healthy donors in Japan Ritsuko Kubota-Koketsu, Yutaka Terada, Mikihiro Yunoki, Tadahiro Sasaki, Emi E. Nakayama, Wataru Kamitani, Tatsuo Shioda
43 [GO] 2020―Oct―10 Seroreactivity with COVID 19 antibody testing in CCP donors presenting without a SARS-CoV-2 diagnostic test Erin K. Goodhue Meyer, Meng Xu, Baia Lasky, Pampee Young
44 [GO] 2020―Oct―08 Transition from Room-Temperature to Cold-Stored Platelets for the Preservation of Blood Inventories during the COVID-19 Pandemic Matthew A Warner, Emil B. Kurian, Scott A. Hammel, Camille M. van Buskirk, Daryl J. Kor, James R. Stubbs
45 [GO] 2020―Oct―03 Evaluating Blood Product Quality Post Expiry to Mitigate Blood Shortages During the COVID -19 Pandemic in Canada Tracey R. Turner, Carly Olafson, Olga Mykhailova, April Xu, Jason P. Acker
46 [GO] 2020―Sep―29 Provision of COVID-19 Convalescent Plasma in a Resource-Constrained State Tina S. Ipe, Tuan Le, Brian Quinn, Stan Kellar, Melisa Clark, Suzanna Carlisle, et al. (+9)
47 [GO] 2020―Sep―26 Characterization of 100 sequential SARS-CoV-2 convalescent plasma donations Christof Jungbauer, Lukas Weseslindtner, Lisa Weidner, Simon Gänsdorfer, Maria R. Farcet, Eva Gschaider-Reichhart, Thomas R. Kreil
48 [GO] 2020―Sep―26 The Need for an Artificial Oxygen Carrier for Disasters and Pandemics, Including COVID -19 Richard B. Weiskopf, Elon Glassberg, Nicole Guinn, Michael F.M. James, Paul M. Ness, Anthony E. Pusateri
49 [GO] 2020―Sep―21 Exploring predictors of Australian community members' blood donation intentions and blood donation-related behavior during the COVID-19 pandemic Barbara M Masser, Melissa K Hyde, Eamonn Ferguson
50 [GO] 2020―Sep―16 Screening for SARS-CoV -2 antibodies in convalescent plasma in Brazil: Preliminary lessons from a voluntary convalescent donor program Silvano Wendel, Jose Mauro Kutner, Rafael Machado, Rita Fontão-Wendel, Carolina Bub, Roberta Fachini, et al. (+15)
51 [GO] 2020―Sep―16 SARS-CoV -2 neutralization and serology testing of COVID -19 convalescent plasma from donors with non-severe disease Thomas J. Gniadek, Joshua M. Thiede, William E. Matchett, Abigail R. Gress, Kathryn A. Pape, Jessica K. Fiege, et al. (+4)
52 [GO] 2020―Aug―28 Blood use and transfusion needs at a large health care system in Washington state during the SARS-CoV -2 pandemic Monica B. Pagano, Guido Cataife, Kleber Yotsumoto Fertrin, Terry Gernsheimer, John R. Hess, Elizabeth Staley, et al. (+4)
53 [GO] 2020―Aug―28 Supply and demand for plasma-derived medicinal products - a critical re-assessment amidst the COVID -19 pandemic Jan Hartmann, Harvey G. Klein
54 [GO] 2020―Aug―25 Persistence of SARS-CoV -2 nasopharyngeal swab PCR positivity in COVID -19 convalescent plasma donors Sachie Ikegami, Robert Benirschke, Tara Flanagan, Nicole Tanna, Tovah Klein, Rita Elue, et al. (+6)
55 [GO] 2020―Aug―20 TRANSFUSION MEDICINE DURING COVID-19 OUTBREAK IN THE HOTSPOT OF SPAIN D Hernández-Maraver, A Viejo, AE Kerguelén, V Jiménez-Yuste
56 [GO] 2020―Aug―15 Risk of Transmission of Severe Acute Respiratory Syndrome Coronavirus-2 by Transfusion: A Literature Review Jean-François Leblanc, Marc Germain, Gilles Delage, Sheila O’Brien, Steven J. Drews, Antoine Lewin
57 [GO] 2020―Aug―15 Development and Evaluation of a Novel RT-PCR System for Reliable and Rapid SARS-CoV-2 Screening of Blood Donations Meng Li, Yuwei Zhao, Ying Li, Xue Chen, Dongxia Luo, Mei Luo, et al. (+13)
58 [GO] 2020―Aug―10 Tools for rapid analysis of blood usage and inventory during the COVID -19 pandemic Colin Murphy, Bryon Jackson, Magali Fontaine
59 [GO] 2020―Aug―08 Lessons learned from early compassionate use of convalescent plasma on critically ill patients with Covid-19 Miao Liu, Zhen Chen, Meng-Yuan Dai, Jun-Hui Yang, Xiao-Bing Chen, Di Chen, et al. (+11)
60 [GO] 2020―Jul―16 Blood stewardship: Conservation and supply of blood components during the SARS-CoV -2 pandemic Sarah Vossoughi, Katherine Fischkoff, Robert A. DeSimone, Joseph Schwartz
61 [GO] 2020―Jul―15 No evidence of SARS-CoV -2 RNA among blood donors: A multicenter study in Hubei, China Le Chang, Ying Yan, Lei Zhao, Guibin Hu, Lijuan Deng, Dan Su, et al. (+10)
62 [GO] 2020―Jul―06 Blood Donor Recruitment in Guangzhou, China, during the 2019 Novel Coronavirus ( COVID -19) Epidemic Jian Ou-Yang, Shi-Jie Li, Chun-hua Bei, Bo He, Jin-yan Chen, Hua-qin Liang, Yong-shui Fu
63 [GO] 2020―Jul―06 Novel multiple swab method enables high efficiency in SARS-CoV -2 screenings without loss of sensitivity for screening of a complete population Michael Schmidt, Sebastian Hoehl, Annemarie Berger, Heinz Zeichhardt, Kai Hourfar, Sandra Ciesek, Erhard Seifried
64 [GO] 2020―Jun―25 How the COVID -19 Pandemic Changed Cellular Therapy at Columbia University Irving Medical Center/ NewYork-Presbyterian Hospital Yvette C. Tanhehco, Joseph Schwartz
65 [GO] 2020―Jun―20 COVID-19 and ABO blood groups Sunny Dzik, Kent Eliason, Edward B. Morris, Richard M Kaufman, Crystal M. North
66 [GO] 2020―Jun―16 Effective coronavirus reduction by various production steps during the manufacture of plasma-derived medicinal products Tobias Schräder, Julia Koch, Rachael Ross, Wolfram Schäfer, Björn Keiner, Nathan J. Roth, Eleonora Widmer
67 [GO] 2020―Jun―16 Is SARS-CoV -2 transfusion transmitted? Louis M. Katz
68 [GO] 2020―Jun―03 Feasibility of a Pilot Program for COVID-19 Convalescent Plasma Collection in Wuhan, China Ling Li, Ru Yang, Jue Wang, Qilu Lv, Ming Ren, Lei Zhao, et al. (+12)
69 [GO] 2020―May―06 Convalescent plasma to treat coronavirus disease 2019 (COVID-19): considerations for clinical trial design Paul Barone, Robert A. DeSimone
70 [GO] 2020―May―06 COVID-19 convalescent plasma: phase 2 C. Michael Knudson, J. Brooks Jackson
71 [GO] 2020―May―03 SARS-CoV -2 asymptomatic and symptomatic patients and risk for transfusion transmission Victor M. Corman, Holger F. Rabenau, Ortwin Adams, Doris Oberle, Markus B. Funk, Brigitte Keller-Stanislawski, et al. (+3)
72 [GO] 2020―May―02 Convalescent plasma: possible therapy for novel coronavirus disease 2019 Huiling Cao, Yuan Shi
73 [GO] 2020―Mar―21 Prepare to adapt: Blood supply and transfusion support during the first 2 weeks of the 2019 Novel Coronavirus (COVID-19) pandemic affecting Washington State Monica B. Pagano, John R. Hess, Hamilton C. Tsang, Elizabeth Staley, Terry Gernsheimer, Nina Sen, et al. (+4)


Last change 2021―Jun―30 20:09:44 UTC

© Daten-Quadrat 2021       Done in 0.202 sec